Inhibition of P-selectin attenuates neutrophil-mediated myocardial dysfunction in isolated rat heart

European Journal of Pharmacology

Volumn 366, Issue 2-3, 1999, Pages 271-279

  Ohnishi, Masako ^a   Yamada, Kazuto ^a   Morooka, Shigeaki ^b   Tojo, Shinichiro J ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b Sakai Chemical Industry   (Japan)

Author keywords

Ischemia and reperfusion injury; Neutrophil; P selectin; Stunning

Indexed keywords

MONOCLONAL ANTIBODY; PADGEM PROTEIN; SIALYL LEWIS X OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN TISSUE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STUNNED HEART MUSCLE;

ANIMALS; ANTIBODIES, MONOCLONAL; CORONARY CIRCULATION; HEART; HEMODYNAMIC PROCESSES; HUMANS; MALE; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; OLIGOSACCHARIDES; P-SELECTIN; RATS; RATS, WISTAR; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0033025142     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00923-6     Document Type: Article

References (35)

1. Bevilacqua M.P., Nelson R.M. Selectins. J. Clin. Invest. 91:1993;379-387.
2. Bolli R. Mechanism of myocardial 'stunning'. Circulation. 82:1990;723-738.
3. Buerke M., Weyrich A.S., Zheng Z., Gaeta F.C.A., Forrest M.J., Lefer A.M. Sialyl Lewis X-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest. 93:1994;1140-1148.
4. Camici P.G., Wijns W., Borgers M., De Silva R., Ferrari R., Knuuti J., Lammertsma A.A., Liedtke A.J., Paternostro G., Vatner S.F. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation. 96:1997;3205-3214.
5. Carden D.L., Smith J.K., Korthuis R.J. Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle. Circ. Res. 66:1990;1436-1444.
6. DeLano F.A., Forrest M.J., Schmid-Schonbein G.W. Attenuation of oxygen free radical formation and tissue injury during experimental inflammation by P-selectin blockade. Microcirculation. 4:1997;349-357.
7. Del Zoppo G.J., Schmid-Schonbein G.W., Mori E., Copeland B.R., Chang C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 22:1991;1276-1283.
8. Engler, R., Covell, J.W., 1987. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. 61, 20-28.
9. Engler R.L., Schmid-Schonbein G.W., Pavelec R.S. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am. J. Pathol. 111:1983;98-111.
10. Henricks P.A.J., Nijkamp F.P. Pharmacological modulation of cell adhesion molecules. Eur. J. Pharmacol. 344:1998;1-13.
11. Jacobson P.B., Phillips M.L., Lefer D.J. Recovery of contractile dysfunction in a rat model of myocardial stunning by a sialyl-Lewis X oligosaccharide ligand for P-selectin. FASEB J. 9:1995;A621.
12. Jerome S.N., Dore M., Paulson J.C., Smith W.C., Korthuis R.J. P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. Am. J. Physiol. 266:1994;H1316-H1321.
13. Lefer D.J., Flynn D.M., Phillips L.M., Ratcliffe M., Buda A.J. A novel sialyl Lewis X analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation. 90:1994;2390-2401.
14. Lefer D.J., Flynn D.M., Buda A.J. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. Am. J. Physiol. 270:1996;H88-H98.
15. Ma X.L., Weyrich A.S., Lefer D.J., Buerke M., Albertine K.H., Kishimoto T.K., Lefer A.M. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation. 88:1993;649-658.
16. Miura T., Nelson D.P., Schermerhorn M.L., Shin'oka T., Zund G., Hickey P.R., Neufeld E.J., Mayer J.E. Blockade of selectin-mediated leukocyte adhesion improved postischemic function in lamb hearts. Ann. Thorac. Surg. 62:1996;1295-1300.
17. Moreyra A.E., Conway R.S., Wilson A.C., Chen W.H., Schmidling M.J., Kostis J.B. Attenuation of myocardial stunning in isolated rat hearts by a 21-aminosteroid lazaroid (U74389G). J. Cardiovasc. Pharmacol. 28:1996;659-664.
18. Mulligan M.S., Polly M.J., Bayer R.J., Nunn M.F., Paulson J.C., Ward P.A. Neutrophil-dependent acute lung injury: requirement for P-selectin (GMP-140). J. Clin. Invest. 90:1992;1600-1607.
19. Mulligan M.S., Lowe J.B., Larsen R.D., Paulson J.C., Zheng Z.L., DeFrees S., Maemura K., Fukuda M., Ward P.A. Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J. Exp. Med. 178:1993;623-631.
20. Mulligan M.S., Paulson J.C., DeFrees S., Zheng Z.L., Lowe J.B., Ward P.A. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature. 364:1993;149-151.
21. Ohnishi M., Koike H., Kawamura N., Tojo S.J., Hayashi M., Morooka S. Role of P-selectin in the early stage of the Arthus reaction. Immunopharmacology. 34:1996;161-170.
22. Phillips L.M., Schwartz B.R., Etzioni A., Bayer R., Ochs H.D., Paulson J.C., Harlan J.M. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J. Clin. Invest. 96:1995;2898-2906.
23. Ritter L.S., McDonagh P.F. Low-reflow reperfusion after myocardial ischemia enhances leukocyte accumulation in coronary microcirculation. Am. J. Physiol. 273:1997;H1154-H1165.
24. Seko Y., Enokawa Y., Nakao T., Yagita H., Okumura K., Yazaki Y. Reduction of rat myocardial ischemia/reperfusion injury by a synthetic selectin oligopeptide. J. Pathol. 178:1996;335-342.
25. Shandelya S.M.L., Kuppusamy P., Weisfeldt M.L., Zweier J.L. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury; evidence for plasma-mediated leukocyte activation. Circulation. 87:1993;536-546.
26. Tedder T.F., Steeber D.A., Chen A., Engel P. The selectins: vascular adhesion molecules. FASEB J. 9:1995;866-873.
27. Tojo S.J., Yokota S., Koike H., Schultz J., Hamazume Y., Misugi E., Yamada K., Hayashi M., Paulson J.C., Morooka S. Reduction of rat myocardial ischemia and reperfusion injury by sialyl Lewis X oligosaccharide and anti-rat P-selectin antibodies. Glycobiology. 6:1996;463-469.
28. Ueyama T., Ikeda H., Haramaki N., Kuwano K., Imaizumi T. Effects of monoclonal antibody to P-selectin and analogue of sialyl Lewis X on cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation. 95:1997;1554-1559.
29. Varki A. Selectin ligands. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7390-7397.
30. Varki A. Selectin ligands: will the real ones please stand up? J. Clin. Invest. 99:1997;158-162.
31. Westlin W., Mullane K.M. Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation. 80:1989;1828-1836.
32. Weyrich A.S., Ma X.L., Lefer D.J., Albertine K.H., Lefer A.M. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:1993;2620-2629.
33. Williams F.M. Neutrophils and myocardial reperfusion injury. Pharmacol. Ther. 72:1996;1-12.
34. Winn R.K., Liggitt D., Vedder N.B., Paulson J.C., Harlan J.M. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J. Clin. Invest. 92:1993;2042-2047.
35. Yamada K., Tojo S.J., Hayashi M., Morooka S. The role of P-selectin, sialyl Lewis X and sulfatide in myocardial ischemia and reperfusion injury. Eur. J. Pharmacol. 346:1998;217-225.